CollPlant Biotechnologies Ltd. (CLGN) Financials

CLGN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 9.2 million 4.3 million
Dec. 31, 2025 10.8 million 4.7 million
Sept. 30, 2025 14.1 million 4.8 million
June 30, 2025 17.4 million 4.9 million

CLGN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -3.1 million 180000
Dec. 31, 2025 -3.2 million -18000
Sept. 30, 2025 -2.9 million 282000
June 30, 2025 -2.4 million 356000

CLGN Net Income

No data available :(

CLGN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 4.3 million - 2.6 million
Dec. 31, 2025 6.0 million - 2.0 million
Sept. 30, 2025 8.5 million - 2.9 million
June 30, 2025 11.7 million - 3.0 million

CLGN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 13.7 million
Dec. 31, 2025 12.8 million
Sept. 30, 2025 12.7 million
June 30, 2025 11.8 million

CLGN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 6000 1.7 million 1.2 million -
Dec. 31, 2025 16106 2.0 million 822000 -
Sept. 30, 2025 1000 2.1 million 1.0 million -
June 30, 2025 3000 2.0 million 929000 -

CLGN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 73000 316000
Dec. 31, 2025 60000 408000
Sept. 30, 2025 77000 492000
June 30, 2025 179000 415000

CLGN

Price: $0.34

52 week price:
0.27
3.23

Earnings Per Share: -1.04 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Israel

Volume: 28000

Market Capitalization: 4.8 million

Links: